skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:020243/0259   Pages: 14
Recorded: 12/14/2007
Attorney Dkt #:28967/5454F
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 47
1
Patent #:
5776755
Issue Dt:
07/07/1998
Application #:
08340011
Filing Dt:
11/14/1994
Title:
FLT4, A RECEPTOR TYROSINE KINASE
2
Patent #:
6221839
Issue Dt:
04/24/2001
Application #:
08510133
Filing Dt:
08/01/1995
Title:
FH4 LIGAND AND METHODS OF USE
3
Patent #:
6245530
Issue Dt:
06/12/2001
Application #:
08585895
Filing Dt:
01/12/1996
Title:
RECEPTOR LIGAND
4
Patent #:
6403088
Issue Dt:
06/11/2002
Application #:
08601132
Filing Dt:
02/14/1996
Title:
ANTIBODIES REACTIVE WITH VEGF-C, A LIGAND FOR THE FLT4 RECEPTOR TYROSINE KINASE ( VEGFR-3)
5
Patent #:
6645933
Issue Dt:
11/11/2003
Application #:
08671573
Filing Dt:
06/28/1996
Title:
RECEPTOR LIGAND VEGF-C
6
Patent #:
6130071
Issue Dt:
10/10/2000
Application #:
08795430
Filing Dt:
02/05/1997
Title:
VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) ACYS 106 PROTEIN AND GENE, AND USES THEREOF
7
Patent #:
6107046
Issue Dt:
08/22/2000
Application #:
08901710
Filing Dt:
07/28/1997
Title:
ANTIBODIES TO FLT4, A RECEPTOR TYROSINE KINASE AND USES THEREOF
8
Patent #:
6235713
Issue Dt:
05/22/2001
Application #:
08915795
Filing Dt:
08/21/1997
Title:
VASCULAR ENDOTHELIAL GROWTH FACTOR-D (VEGF-D) POLYPEPTIDES
9
Patent #:
6824777
Issue Dt:
11/30/2004
Application #:
09169079
Filing Dt:
10/09/1998
Title:
FLT4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
10
Patent #:
7947472
Issue Dt:
05/24/2011
Application #:
09219345
Filing Dt:
12/23/1998
Publication #:
US20020127222
Pub Dt:
09/12/2002
Title:
EXPRESSION VECTORS AND CELL LINES EXPRESSING VASCULAR ENDOTHELIAL GROWTH FACTOR D
11
Patent #:
6689580
Issue Dt:
02/10/2004
Application #:
09296275
Filing Dt:
04/22/1999
Title:
POLYNUCLEOTIDES ENCODING VASCULAR ENDOTHELIAL GROWTH FACTOR D (VEGF-D)
12
Patent #:
6361946
Issue Dt:
03/26/2002
Application #:
09355700
Filing Dt:
11/05/1999
Title:
VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) PROTEIN AND GENE, MUTANTS THEREOF, AND USES THEREOF
13
Patent #:
6515105
Issue Dt:
02/04/2003
Application #:
09421365
Filing Dt:
10/19/1999
Title:
NOVEL NEUROPILIN/GROWTH FACTOR COMPLEXES AND USES THEREOF
14
Patent #:
6818220
Issue Dt:
11/16/2004
Application #:
09534376
Filing Dt:
03/24/2000
Title:
VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) PROTEIN AND GENE MUTANTS THEREOF, AND USES THEREOF
15
Patent #:
6730658
Issue Dt:
05/04/2004
Application #:
09631092
Filing Dt:
08/02/2000
Title:
STIMULATION OF LYMPHATIC GROWTH WITH AN FLT4 LIGAND
16
Patent #:
7034105
Issue Dt:
04/25/2006
Application #:
09765534
Filing Dt:
01/19/2001
Publication #:
US20040037820
Pub Dt:
02/26/2004
Title:
FLT4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
17
Patent #:
6965010
Issue Dt:
11/15/2005
Application #:
09795006
Filing Dt:
02/26/2001
Publication #:
US20020151680
Pub Dt:
10/17/2002
Title:
MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAS AND PROTEINS
18
Patent #:
7611711
Issue Dt:
11/03/2009
Application #:
10046922
Filing Dt:
01/15/2002
Publication #:
US20020164667
Pub Dt:
11/07/2002
Title:
VEGFR-3 INHIBITOR MATERIALS AND METHODS
19
Patent #:
7410639
Issue Dt:
08/12/2008
Application #:
10161694
Filing Dt:
06/05/2002
Publication #:
US20030125537
Pub Dt:
07/03/2003
Title:
VASCULAR ENDOTHELIAL GROWTH FACTOR D(VEGF-D) ANTIBODIES AND METHODS OF USE
20
Patent #:
7125714
Issue Dt:
10/24/2006
Application #:
10201386
Filing Dt:
07/23/2002
Publication #:
US20030091567
Pub Dt:
05/15/2003
Title:
PROGENITOR CELL MATERIALS AND METHODS
21
Patent #:
NONE
Issue Dt:
Application #:
10262538
Filing Dt:
09/30/2002
Publication #:
US20030113324
Pub Dt:
06/19/2003
Title:
Neuropilin/VEGF-C/VEGFR-3 materials and methods
22
Patent #:
7122654
Issue Dt:
10/17/2006
Application #:
10274953
Filing Dt:
10/22/2002
Publication #:
US20030114658
Pub Dt:
06/19/2003
Title:
VASCULAR ENDOTHELIAL GROWTH FACTOR D (VEGF-D) ANTIBODIES AND VECTORS, AND METHODS OF USE
23
Patent #:
7420042
Issue Dt:
09/02/2008
Application #:
10303786
Filing Dt:
11/26/2002
Publication #:
US20030125523
Pub Dt:
07/03/2003
Title:
SOLUBLE NEUROPILIN/GROWTH FACTOR RECEPTOR FUSION PROTEINS
24
Patent #:
NONE
Issue Dt:
Application #:
10326048
Filing Dt:
12/20/2002
Publication #:
US20040120950
Pub Dt:
06/24/2004
Title:
Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis
25
Patent #:
NONE
Issue Dt:
Application #:
10483203
Filing Dt:
09/07/2004
Publication #:
US20060269548
Pub Dt:
11/30/2006
Title:
Lymphatic endothelial cells materials and methods
26
Patent #:
NONE
Issue Dt:
Application #:
10505928
Filing Dt:
09/08/2005
Publication #:
US20060088532
Pub Dt:
04/27/2006
Title:
Lymphatic and blood endothelial cell genes
27
Patent #:
NONE
Issue Dt:
Application #:
10570963
Filing Dt:
10/02/2006
Publication #:
US20070110744
Pub Dt:
05/17/2007
Title:
Lymphatic and blood endothelial cell genes
28
Patent #:
7829091
Issue Dt:
11/09/2010
Application #:
10774802
Filing Dt:
02/09/2004
Publication #:
US20040208879
Pub Dt:
10/21/2004
Title:
THERAPY TARGETING FLT4 (VEGER-3) EXPRESSED IN BLOOD VESSELS
29
Patent #:
7423125
Issue Dt:
09/09/2008
Application #:
10792461
Filing Dt:
03/03/2004
Publication #:
US20040147726
Pub Dt:
07/29/2004
Title:
ANTIBODIES TO VEGF-C
30
Patent #:
7727761
Issue Dt:
06/01/2010
Application #:
10792480
Filing Dt:
03/03/2004
Publication #:
US20040147448
Pub Dt:
07/29/2004
Title:
VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) PROTEIN AND GENE, MUTANTS THEREOF, AND USES THEREOF
31
Patent #:
NONE
Issue Dt:
Application #:
10868549
Filing Dt:
06/14/2004
Publication #:
US20050043235
Pub Dt:
02/24/2005
Title:
Use of VEGF-C or VEGF-D in reconstructive surgery
32
Patent #:
NONE
Issue Dt:
Application #:
10868577
Filing Dt:
06/14/2004
Publication #:
US20050032697
Pub Dt:
02/10/2005
Title:
Heparin binding VEGFR-3 ligands
33
Patent #:
8455453
Issue Dt:
06/04/2013
Application #:
11064769
Filing Dt:
02/24/2005
Publication #:
US20050256075
Pub Dt:
11/17/2005
Title:
Use of VEGF-D gene to prevent restenosis
34
Patent #:
7309604
Issue Dt:
12/18/2007
Application #:
11064774
Filing Dt:
02/24/2005
Publication #:
US20050267024
Pub Dt:
12/01/2005
Title:
MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAS AND PROTEINS
35
Patent #:
NONE
Issue Dt:
Application #:
11074373
Filing Dt:
03/07/2005
Publication #:
US20060024302
Pub Dt:
02/02/2006
Title:
Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
36
Patent #:
7422741
Issue Dt:
09/09/2008
Application #:
11075047
Filing Dt:
03/07/2005
Publication #:
US20060030000
Pub Dt:
02/09/2006
Title:
VEGFR-3 FUSION PROTEINS
37
Patent #:
NONE
Issue Dt:
Application #:
11075400
Filing Dt:
03/07/2005
Publication #:
US20050282233
Pub Dt:
12/22/2005
Title:
Multivalent antibody materials and methods for VEGF/PDGF family of growth factors
38
Patent #:
NONE
Issue Dt:
Application #:
11076427
Filing Dt:
03/08/2005
Publication #:
US20060025338
Pub Dt:
02/02/2006
Title:
Compositions and methods for treatment of lymphatic and venous vessel arterialization
39
Patent #:
NONE
Issue Dt:
Application #:
11304585
Filing Dt:
12/16/2005
Publication #:
US20060177428
Pub Dt:
08/10/2006
Title:
ANTISENSE NUCLEIC ACID SEQUENCE TO VASCULAR ENDOTHELIAL GROWTH FACTOR D (VEGF - D)
40
Patent #:
8940695
Issue Dt:
01/27/2015
Application #:
11327075
Filing Dt:
01/06/2006
Publication #:
US20060177901
Pub Dt:
08/10/2006
Title:
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
41
Patent #:
8025886
Issue Dt:
09/27/2011
Application #:
11505100
Filing Dt:
08/15/2006
Publication #:
US20070142282
Pub Dt:
06/21/2007
Title:
MODIFIED VEGF-A WITH IMPROVED ANGIOGENIC PROPERTIES
42
Patent #:
NONE
Issue Dt:
Application #:
11600479
Filing Dt:
11/16/2006
Publication #:
US20070082848
Pub Dt:
04/12/2007
Title:
VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
43
Patent #:
NONE
Issue Dt:
Application #:
11692753
Filing Dt:
03/28/2007
Publication #:
US20080145366
Pub Dt:
06/19/2008
Title:
Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
44
Patent #:
7662932
Issue Dt:
02/16/2010
Application #:
11772089
Filing Dt:
06/29/2007
Publication #:
US20080058258
Pub Dt:
03/06/2008
Title:
VASCULAR ENDOTHELIAL GROWTH FACTOR D (VEGF-D) POLYPEPTIDES AND METHODS OF USE
45
Patent #:
NONE
Issue Dt:
Application #:
11782225
Filing Dt:
07/24/2007
Publication #:
US20080147045
Pub Dt:
06/19/2008
Title:
Use of VEGF-C or VEGF-D in Reconstructive Surgery
46
Patent #:
7863851
Issue Dt:
01/04/2011
Application #:
11843367
Filing Dt:
08/22/2007
Publication #:
US20090051310
Pub Dt:
02/26/2009
Title:
CLOSED LOOP STEPPER MOTOR CONTROL
47
Patent #:
7566566
Issue Dt:
07/28/2009
Application #:
11846337
Filing Dt:
08/28/2007
Publication #:
US20080058263
Pub Dt:
03/06/2008
Title:
MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAS AND PROTEINS
Assignors
1
LUDWIG INSTITUTE FOR CANCER RESEARCH
Exec Dt:
12/03/2007
2
LICENTIA LTD.
Exec Dt:
12/07/2007
Assignee
1
VEGENICS LIMITED
LEVEL 1, 10 WALLACE AVE.
TOORAK, VICTORIA, AUSTRALIA 3142
Correspondence name and address
MARSHALL, GERSTEIN & BORUN LLP
233 SOUTH WACKER DRIVE
6300 SEARS TOWER
CHICAGO, IL 60606-6357

Search Results as of: 06/05/2024 08:08 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT